<DOC>
	<DOCNO>NCT01321606</DOCNO>
	<brief_summary>The investigator two hypothesis : ( 1 ) The probiotic L. rhamnosus HN001 , compare placebo , reduce S. aureus nasal colonization take four week . ( 2 ) The probiotic L. rhamnosus HN001 , compare placebo , reduce S. aureus gastrointestinal colonization take four week .</brief_summary>
	<brief_title>Impact Probiotics Reducing Infections Veterans : The IMPROVE Study</brief_title>
	<detailed_description>Reducing infection cause S. aureus essential . The knowledge colonization key body sit nose gastrointestinal tract prerequisite infection2 ,3 offer opportunity therapeutic intervention . Thirty percent population nasal colonization S. aureus . In last year , decolonization agent mupirocin topical ointment oral antibiotic doxycycline rifampin study utility reduce colonization . However , option limitation recolonization common , impact intervention multiple site colonization assess resistance develops frequently , especially oral antibiotic . Resistance S. aureus designate public health crisis . Methicillin-resistant S. aureus ( MRSA ) account 60 % S. aureus infection . As example grow crisis S. aureus resistance , note number MRSA infection rise 2000 1993 368,000 2005 . MRSA infection pose even great health economic burden population cause methicillin-sensitive S. aureus.4-8 S. aureus MRSA infection trend VA health system mirror national trends5 associate considerable morbidity mortality Veterans . A treatment reduce S. aureus MRSA colonization , without risk promote antibiotic resistance could represent breakthrough decolonization therapy . Probiotics may one treatment option . Probiotics live microorganism available counter , widely use dietary supplement nutritional food represent low-cost , well tolerate , safe , non-antibiotic base strategy may efficacy decolonization without attendant risk promote antimicrobial resistance.9 Certain probiotic , include Lactobacillus rhamnosus HN001 , demonstrate ability stimulate systemic immune function , possibly enhance body 's ability eradicate S. aureus gastrointestinal tract site remote gastrointestinal tract nose.10 ,11 The long-term goal research identify test novel intervention reduce infection cause resistant bacteria . The investigator propose Phase II randomize , double-blind , placebo-controlled clinical trial Veterans evaluate efficacy oral probiotic , Lactobacillus rhamnosus HN001 , reduce S. aureus colonization . This study produce data , method , tool widespread relevance portability , potential reduce healthcare-associated infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<criteria>Colonized nasal gastrointestinal source S. aureus include MRSA Age 18 year older Able take oral medication Able provide inform consent Uncontrolled psychiatric illness On decolonization protocol MRSA ( e.g mupirocin , tea tree oil ) Current involvement another investigational trial Pregnancy Persistent diarrhea ( &gt; 3 loose stool per day least 2 day ) Active infection S.aureus MRSA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>infection</keyword>
	<keyword>probiotic</keyword>
</DOC>